Cargando…
Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation
AIMS: Premature cardiovascular events complicate chronic inflammatory conditions. Low-dose weekly methotrexate (MTX), the most widely used disease-modifying drug for rheumatoid arthritis (RA), reduces disease-associated cardiovascular mortality. MTX increases intracellular accumulation of adenosine...
Autores principales: | Thornton, C C, Al-Rashed, F, Calay, D, Birdsey, G M, Bauer, A, Mylroie, H, Morley, B J, Randi, A M, Haskard, D O, Boyle, J J, Mason, J C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752671/ https://www.ncbi.nlm.nih.gov/pubmed/25575725 http://dx.doi.org/10.1136/annrheumdis-2014-206305 |
Ejemplares similares
-
Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling
por: Al-Rashed, Fahad, et al.
Publicado: (2018) -
PKCε-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosis
por: Mylroie, Hayley, et al.
Publicado: (2015) -
Identification of cyclins A1, E1 and vimentin as downstream targets of heme oxygenase-1 in vascular endothelial growth factor-mediated angiogenesis
por: Bauer, Andrea, et al.
Publicado: (2016) -
Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism
por: Municio, Cristina, et al.
Publicado: (2018) -
The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
por: Deng, Jiaojiao, et al.
Publicado: (2020)